Fred Alger Management, LLC Forte Biosciences, Inc. Transaction History

Fred Alger Management, LLC

$19.8 Billion
Q3 2024

Shares

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q3 2023 Nov 14, 2023	BUY	$0.65 - $1.04 $1.2 Million - $1.91 Million	1,838,965 New	1,838,965 $1.21 Million
Q3 2021 Nov 15, 2021	SELL	$2.96 - $36.67 $3.6 Million - $44.6 Million	-1,217,537 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$31.5 - $42.5 $20.8 Million - $28.1 Million	660,438 Added 118.55%	1,217,537 $40.9 Million
Q1 2021 May 17, 2021	BUY	$25.01 - $40.24 $1.85 Million - $2.98 Million	74,063 Added 15.33%	557,099 $19.1 Million
Q4 2020 Feb 16, 2021	BUY	$28.66 - $46.79 $493,066 - $804,975	17,204 Added 3.69%	483,036 $17.6 Million
Q3 2020 Nov 13, 2020	SELL	$14.71 - $50.69 $3.8 Million - $13.1 Million	-258,312 Reduced 35.67%	465,832 $22.6 Million
Q2 2020 Aug 14, 2020	BUY	$13.9 - $24.6 $10.1 Million - $17.8 Million	724,144 New	724,144 $10.6 Million

Others Institutions Holding FBRX

# of Institutions

1

Shares Held

175K

Call Options Held

0

Put Options Held

0

Black Rock Inc. New York, NY

175K
Shares

$977,456
0.0% of portfolio

About Forte Biosciences, Inc.

Ticker FBRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,340,300
Market Cap $114M
Description
Forte Biosciences, Inc. operates as a clinical-stage biopharmaceutical company in the United States. It is developing FB-102 program that addresses various autoimmune diseases, such as vitiligo and alopecia areata. The company is headquartered in Dallas, Texas.

More about FBRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fred Alger Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fred Alger Management, LLC with notifications on news.